Spotlight on Asia

Premium

By John S. MacNeil

In the US and Europe, businesses and policymakers worry about how to create the next biotech center of excellence in their own backyard. Is it just a matter of pumping money into a fancy new research institution or encouraging venture capital investment, they wonder, or is there something deeper and more entrenched, like a long-standing tradition of academic excellence at local universities that also encourage their researchers to transfer their discoveries into the private sector?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Wired reports that 23andMe is trying to bolster its outside collaborations.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.